Medicovestor
Highly Engaged Employees
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
New York City, New York, United StatesWebsite
www.medicovestor.comRevenue
<$5 MillionIndustry
About Medicovestor
Medicovestor Org Chart
Is Medicovestor your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Medicovestor recently announced quarterly report
Product Launch: Get notified when Medicovestor launches new products
Click to see if Medicovestor had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Medicovestor
Check out if Medicovestor is spiking on competitors!
Medicovestor, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Medicovestor has new funding data
Website visits: Recent activity has been detected on your website
Check if Medicovestor has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Medicovestor
Compare insights from companies similar to Medicovestor, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Medicovestor is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Medicovestor is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Medicovestor.
Medicovestor Tech Stack
A closer look at the technologies used by Medicovestor
Most Recent Scoops
Medicovestor News & Media
FDA Grants Orphan Drug Designation to Medicovestor’s First-in-Class ADC for Pancreatic Cancer
FDA grants Orphan Drug Designation to Medicovestor’s ADoBind MC001, a novel ADC targeting hard-to-treat pancreatic cancer.Medicovestor, Inc. and Sanyou Biopharmaceuticals Forge Strategic Partnership to Develop First-in-Class Chemoimmunotherapy Antibody-Drug Conjugates
Medicovestor and Sanyou team up to develop first-in-class chemoimmunotherapy ADCs, combining AI antibody tech with novel dual-targeting platforms.Medicovestor, Inc. Announces Issuance/Approval of 3 Patents by the USPTO
Medicovestor secures 3 USPTO patents, advancing its innovative ADC platform and unique antibodies for enhanced cancer treatment and autoimmune potential.Medicovestor Selected as Finalist to Present Its First-in-Class ADC Platforms at JP Morgan Asset Management: Life Sciences Innovation Summit
Medicovestor named finalist for JP Morgan Asset Management: Life Sciences Innovation Summit, showcasing pioneering ADC platforms on May 14th – 15th, 2024.
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Medicovestor
Medicovestor Inc. stands at the forefront of leveraging the potent capabilities of antibodies to revolutionize cancer treatment. The company's mission is centered on harnessing the power of antibodies to create revolutionary precision medicines, pushing the boundaries of traditional therapeutics. By fully unlocking the potential of this extraordina... Read More
